{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:30:46Z","timestamp":1790706646615,"version":"4.1.0"},"reference-count":135,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.jaip.2014.03.006","type":"journal-article","created":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T13:15:48Z","timestamp":1398431748000},"page":"371-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":165,"title":["Skin Barrier and Immune Dysregulation in Atopic Dermatitis: An Evolving Story with Important Clinical Implications"],"prefix":"10.1016","volume":"2","author":[{"given":"Tali","family":"Czarnowicki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Guttman-Yassky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2014.03.006_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/0378-6323.107633","article-title":"Is there something called adult onset atopic dermatitis in India?","volume":"79","author":"Thappa","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaip.2014.03.006_bib2","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMra074081","article-title":"Atopic dermatitis","volume":"358","author":"Bieber","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2014.03.006_bib3","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jaci.2008.01.022","article-title":"Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms","volume":"121","author":"Elias","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib4","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jaci.2011.01.053","article-title":"Contrasting pathogenesis of atopic dermatitis and psoriasis\u2014part I: clinical and pathologic concepts","volume":"127","author":"Guttman-Yassky","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaci.2009.11.027","article-title":"Recent insights into atopic dermatitis and implications for management of infectious complications","volume":"125","author":"Boguniewicz","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib6","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/jid.2008.88","article-title":"\u201cOutside-to-inside\u201d (and now back to \u201coutside\u201d) pathogenic mechanisms in atopic dermatitis","volume":"128","author":"Elias","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaci.2012.12.668","article-title":"The multifunctional role of filaggrin in allergic skin disease","volume":"131","author":"McAleer","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11882-009-0041-2","article-title":"Pathogenesis of atopic dermatitis: new developments","volume":"9","author":"Bieber","year":"2009","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2014.03.006_bib9","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2012.07.012","article-title":"Progressive activation of T(H)2\/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis","volume":"130","author":"Gittler","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/jid.2008.252","article-title":"Evolving concepts of pathogenesis in atopic dermatitis and other eczemas","volume":"129","author":"Hanifin","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jaci.2005.11.038","article-title":"Proceedings of the 4th Georg Rajka International Symposium on Atopic Dermatitis, Arcachon, France, September 15-17, 2005","volume":"117","author":"Taieb","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/1523-1747.ep12338501","article-title":"Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex (\u201cepidermal differentiation complex\u201d) on human chromosome 1q21","volume":"106","author":"Mischke","year":"1996","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1006\/geno.1993.1430","article-title":"Physical mapping of a functional cluster of epidermal differentiation genes on chromosome-1q21","volume":"18","author":"Volz","year":"1993","journal-title":"Genomics"},{"key":"10.1016\/j.jaip.2014.03.006_bib14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nrm1619","article-title":"The cornified envelope: a model of cell death in the skin","volume":"6","author":"Candi","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jaip.2014.03.006_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2009.11.008","article-title":"An update on the genetics of atopic dermatitis: scratching the surface in 2009","volume":"125","author":"Barnes","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaci.2008.08.002","article-title":"Filaggrin in atopic dermatitis","volume":"122","author":"O\u2019Regan","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.jaip.2014.03.006_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1396-0296.2004.04S1005.x","article-title":"Moisturization and skin barrier function","volume":"17","author":"Rawlings","year":"2004","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaip.2014.03.006_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-065X.2011.01027.x","article-title":"Atopic dermatitis: a disease of altered skin barrier and immune dysregulation","volume":"242","author":"Boguniewicz","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaip.2014.03.006_bib19","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jaci.2008.01.013","article-title":"Filaggrin null mutations and childhood atopic eczema: a population-based case-control study","volume":"121","author":"Brown","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng1767","article-title":"Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"Palmer","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2014.03.006_bib21","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jaci.2007.08.067","article-title":"Toward a major risk factor for atopic eczema: Meta-analysis of filaggrin polymorphism data","volume":"120","author":"Baurecht","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib22","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jaci.2008.01.026","article-title":"The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study","volume":"121","author":"Henderson","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib23","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jaci.2009.07.041","article-title":"Our evolving understanding of the functional role of filaggrin in atopic dermatitis","volume":"124","author":"Leung","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib24","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jaci.2009.09.031","article-title":"Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis","volume":"124","author":"Guttman-Yassky","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib25","first-page":"8","article-title":"\u2018Ome sweet \u2018omics: a genealogical treasury of words","volume":"15","author":"Lederberg","year":"2001","journal-title":"Scientist"},{"key":"10.1016\/j.jaip.2014.03.006_bib26","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1101\/gr.096651.109","article-title":"The NIH Human Microbiome Project","volume":"19","author":"NIH HMP Group Working Group","year":"2009","journal-title":"Genome Res"},{"key":"10.1016\/j.jaip.2014.03.006_bib27","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/jid.2011.417","article-title":"Skin microbiome: looking back to move forward","volume":"132","author":"Kong","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib28","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2014.03.006_bib29","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1365-2133.2010.10114.x","article-title":"Staphylococcal-mediated worsening of atopic dermatitis: many players involved","volume":"163","author":"Agner","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-4362.1999.00686.x","article-title":"Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects","volume":"38","author":"Higaki","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1067\/mai.2001.117455","article-title":"Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin","volume":"108","author":"Cho","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib32","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.4049\/jimmunol.171.6.3262","article-title":"Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes","volume":"171","author":"Nomura","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib33","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/jid.2008.74","article-title":"Th2 cytokines act on S100\/A11 to downregulate keratinocyte differentiation","volume":"128","author":"Howell","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5021\/ad.2010.22.2.125","article-title":"Atopic dermatitis","volume":"22","author":"Bieber","year":"2010","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib35","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/sj.jid.5700788","article-title":"Barrier function, epidermal differentiation, and human beta-defensin 2 expression in tinea corporis","volume":"127","author":"Jensen","year":"2007","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/bjd.12419","article-title":"Human beta-defensin-2 as a marker for disease severity and skin barrier properties in atopic dermatitis","volume":"169","author":"Clausen","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib37","doi-asserted-by":"crossref","unstructured":"Brauweiler AM, Goleva E, Leung DY. Th2 Cytokines Increase Staphylococcus aureus alpha toxin induced keratinocyte death through the Signal Transducer and Activator of Transcription 6 (STAT6). J Invest Dermatol (27 January 2014) doi:10.1038\/jid.2014.43. Epub ahead of print.","DOI":"10.1038\/jid.2014.43"},{"key":"10.1016\/j.jaip.2014.03.006_bib38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: a new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib39","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jaci.2011.10.042","article-title":"IL-31 regulates differentiation and filaggrin expression in human organotypic skin models","volume":"129","author":"Cornelissen","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2014.03.006_bib41","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.4049\/jimmunol.178.4.2229","article-title":"The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis","volume":"178","author":"Sa","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cytogfr.2010.08.002","article-title":"Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection","volume":"21","author":"Witte","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jaip.2014.03.006_bib43","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis","volume":"36","author":"Wolk","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib44","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.4049\/jimmunol.173.5.3482","article-title":"IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways","volume":"173","author":"Kao","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.immuni.2005.01.011","article-title":"Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17","volume":"22","author":"Stark","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2014.03.006_bib46","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.4049\/jimmunol.181.10.7420","article-title":"Low expression of the IL-23\/Th17 pathway in atopic dermatitis compared to psoriasis","volume":"181","author":"Guttman-Yassky","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib47","doi-asserted-by":"crossref","first-page":"204ra129","DOI":"10.1126\/scitranslmed.3006245","article-title":"IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis","volume":"5","author":"Wolk","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaip.2014.03.006_bib48","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1067\/mai.2000.105528","article-title":"Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis","volume":"105","author":"Bunikowski","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib49","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/jid.2009.133","article-title":"Epidermal barrier dysfunction in atopic dermatitis","volume":"129","author":"Cork","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib50","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jdermsci.2013.12.004","article-title":"Staphylococcus aureus inhibits terminal differentiation of normal human keratinocytes by stimulating interleukin-6 secretion","volume":"74","author":"Son","year":"2014","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2014.03.006_bib51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1189\/jlb.0112009","article-title":"Staphylococcus aureus directly activates eosinophils via platelet-activating factor receptor","volume":"92","author":"Hosoki","year":"2012","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jaip.2014.03.006_bib52","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.ijid.2011.09.014","article-title":"Skin colonization by superantigen-producing Staphylococcus aureus in Egyptian patients with atopic dermatitis and its relation to disease severity and serum interleukin-4 level","volume":"16","author":"Nada","year":"2012","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jaip.2014.03.006_bib53","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jaci.2010.07.041","article-title":"Staphylococcal exotoxins are strong inducers of IL-22: a potential role in atopic dermatitis","volume":"126","author":"Niebuhr","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib54","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2133.2010.09743.x","article-title":"Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review","volume":"163","author":"Bath-Hextall","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib55","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1067\/mai.2001.118598","article-title":"Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis","volume":"108","author":"Boguniewicz","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib56","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jaci.2013.06.030","article-title":"The ABC\u2019s of managing patients with severe atopic dermatitis","volume":"132","author":"Boguniewicz","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib57","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000323296","article-title":"The antimicrobial skin barrier in patients with atopic dermatitis","volume":"41","author":"Schittek","year":"2011","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib58","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jaci.2009.03.032","article-title":"Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis","volume":"123","author":"Jensen","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib59","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1081-1206(10)60859-9","article-title":"Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics","volume":"98","author":"Hung","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib60","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clim.2006.08.008","article-title":"Mechanism of HBD-3 deficiency in atopic dermatitis","volume":"121","author":"Howell","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib61","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000331910","article-title":"New strategies for dealing with Staphylococcus aureus colonization and the emerging methicillin-resistant Staphylococcus aureus epidemic in atopic dermatitis","volume":"96","author":"Boguniewicz","year":"2012","journal-title":"Chem Immul Allery"},{"key":"10.1016\/j.jaip.2014.03.006_bib62","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2133.2008.08601.x","article-title":"Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study","volume":"159","author":"Sidbury","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2002.tb11448.x","article-title":"Antibacterial properties of cationic steroid antibiotics","volume":"217","author":"Savage","year":"2002","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.jaip.2014.03.006_bib64","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1128\/AAC.01325-06","article-title":"Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureus","volume":"51","author":"Chin","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaip.2014.03.006_bib65","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1086\/589776","article-title":"Neutralization of multiple staphylococcal superantigens by a single-chain protein consisting of affinity-matured, variable domain repeats","volume":"198","author":"Yang","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jaip.2014.03.006_bib66","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fimmu.2013.00507","article-title":"Colonization: modulation of host immune response and impact on human vaccine design","volume":"4","author":"Brown","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib67","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib68","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.4049\/jimmunol.0901860","article-title":"IL-4 regulates skin homeostasis and the predisposition toward allergic skin inflammation","volume":"184","author":"Sehra","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib69","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaci.2007.04.031","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"120","author":"Howell","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib70","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clim.2007.11.006","article-title":"Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6","volume":"126","author":"Kim","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib71","first-page":"1092","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"Nograles","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib72","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/sj.jid.5701138","article-title":"IL-4 suppresses the recovery of cutaneous permeability barrier functions in vivo","volume":"128","author":"Kurahashi","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib73","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.0022-202X.2005.23651.x","article-title":"Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis","volume":"124","author":"Hatano","year":"2005","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib74","doi-asserted-by":"crossref","first-page":"245","DOI":"10.5021\/ad.2010.22.3.245","article-title":"Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis","volume":"22","author":"Elias","year":"2010","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib75","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2013.04.028","article-title":"The role of IL-22 and Th22 cells in human skin diseases","volume":"72","author":"Fujita","year":"2013","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2014.03.006_bib76","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","article-title":"IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes","volume":"174","author":"Boniface","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib77","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1084\/jem.20051745","article-title":"Thymic stromal lymphopoietin: master switch for allergic inflammation","volume":"203","author":"Liu","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2014.03.006_bib78","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/ni1360","article-title":"Thymic stromal lymphopoietin in normal and pathogenic T cell development and function","volume":"7","author":"Ziegler","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib79","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.20051135","article-title":"TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand","volume":"202","author":"Ito","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2014.03.006_bib80","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/jid.2011.435","article-title":"Skin barrier disruption: a requirement for allergen sensitization?","volume":"132","author":"De Benedetto","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib81","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1398-9995.2004.00556.x","article-title":"The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study","volume":"59","author":"Darsow","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2014.03.006_bib82","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jaci.2013.07.051","article-title":"Epicutaneous application of house dust mite induces thymic stromal lymphopoietin in nonlesional skin of patients with atopic dermatitis","volume":"132","author":"Landheer","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib83","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1084\/jem.20070406","article-title":"IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells","volume":"204","author":"Wang","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2014.03.006_bib84","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1084\/jem.20051496","article-title":"Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract","volume":"203","author":"Owyang","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2014.03.006_bib85","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S1074-7613(01)00243-6","article-title":"IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo","volume":"15","author":"Fort","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.jaip.2014.03.006_bib86","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/jid.2010.277","article-title":"IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction?","volume":"131","author":"Hvid","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib87","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/jid.2009.173","article-title":"Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin","volume":"129","author":"Gudjonsson","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib88","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0923-1811(00)00073-6","article-title":"Skin barrier function in patients with completely healed atopic dermatitis","volume":"23","author":"Matsumoto","year":"2000","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2014.03.006_bib89","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.0022-202X.2004.22621.x","article-title":"Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis","volume":"122","author":"Jensen","year":"2004","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib90","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/00015559850135788","article-title":"Ceramide and cholesterol composition of the skin of patients with atopic dermatitis","volume":"78","author":"Di Nardo","year":"1998","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2014.03.006_bib91","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2340\/0001555565102105","article-title":"Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis","volume":"65","author":"Werner","year":"1985","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2014.03.006_bib92","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI117408","article-title":"Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis","volume":"94","author":"Hamid","year":"1994","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2014.03.006_bib93","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jaci.2010.12.1124","article-title":"Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities","volume":"127","author":"Suarez-Farinas","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib94","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaci.2011.05.042","article-title":"Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response","volume":"128","author":"Tintle","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib95","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.jaci.2014.03.003","article-title":"Cyclosporine a in atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology","volume":"133","author":"Khattri","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib96","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jdermsci.2006.06.003","article-title":"Skin barrier function, epidermal proliferation and differentiation in eczema","volume":"43","author":"Proksch","year":"2006","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2014.03.006_bib97","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/(SICI)1097-0320(19991001)37:2<147::AID-CYTO8>3.0.CO;2-Y","article-title":"Phenotyping of epidermal dendritic cells: clinical applications of a flow cytometric micromethod","volume":"37","author":"Wollenberg","year":"1999","journal-title":"Cytometry"},{"key":"10.1016\/j.jaip.2014.03.006_bib98","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1067\/mai.2003.1626","article-title":"Surface expression of Fc epsilon RI on Langerhans\u2019 cells of clinically uninvolved skin is associated with disease activity in atopic dermatitis, allergic asthma, and rhinitis","volume":"112","author":"Semper","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib99","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5021\/ad.2012.24.3.253","article-title":"Long term treatment concepts and proactive therapy for atopic eczema","volume":"24","author":"Wollenberg","year":"2012","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib100","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1523-1747.2002.01833.x","article-title":"Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis","volume":"119","author":"Macheleidt","year":"2002","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib101","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1468-3083.2005.01249.x","article-title":"Position paper on diagnosis and treatment of atopic dermatitis","volume":"19","author":"Darsow","year":"2005","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2014.03.006_bib102","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1398-9995.2008.01803.x","article-title":"Proactive therapy of atopic dermatitis: an emerging concept","volume":"64","author":"Wollenberg","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2014.03.006_bib103","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1136\/bmj.326.7403.1367","article-title":"Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study","volume":"326","author":"Berth-Jones","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2014.03.006_bib104","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2133.2002.05006.x","article-title":"Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients","volume":"147","author":"Hanifin","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib105","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1398-9995.2007.01406.x-i1","article-title":"Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment","volume":"63","author":"Wollenberg","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2014.03.006_bib106","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/j.1365-2133.2010.09904.x","article-title":"Proactive treatment appears to decrease serum immunoglobulin-E levels in patients with severe atopic dermatitis","volume":"163","author":"Fukuie","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib107","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/1523-1747.ep12277574","article-title":"Occurrence of IgE-bearing epidermal Langerhans cells in atopic eczema: a study of the time course of the lesions and with regard to the IgE serum level","volume":"93","author":"Bieber","year":"1989","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib108","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1084\/jem.175.5.1285","article-title":"Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI)","volume":"175","author":"Bieber","year":"1992","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2014.03.006_bib109","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1034\/j.1398-9995.2000.00552.x","article-title":"The skin as a target for allergic diseases","volume":"55","author":"Novak","year":"2000","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2014.03.006_bib110","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1034\/j.1398-9995.2001.00144.x","article-title":"Epidemiology, clinical features, and immunology of the \u201cintrinsic\u201d (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis)","volume":"56","author":"Schmid","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2014.03.006_bib111","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1038\/jid.2008.80","article-title":"Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis","volume":"128","author":"Altrichter","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib112","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1146\/annurev.immunol.21.120601.141103","article-title":"The biology of IGE and the basis of allergic disease","volume":"21","author":"Gould","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib113","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jdermsci.2012.04.004","article-title":"A\u00a0group of atopic dermatitis without IgE elevation or barrier impairment shows a high Th1 frequency: possible immunological state of the intrinsic type","volume":"67","author":"Kabashima-Kubo","year":"2012","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2014.03.006_bib114","first-page":"1","article-title":"The atopic eczema\/dermatitis syndrome: epidemiology, natural course, and immunology of the IgE-associated (\u201cextrinsic\u201d) and the nonallergic (\u201cintrinsic\u201d) AEDS","volume":"13","author":"Wuthrich","year":"2003","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2133.2009.09440.x","article-title":"Comparison of skin barrier function and sensory nerve electric current perception threshold between IgE-high extrinsic and IgE-normal intrinsic types of atopic dermatitis","volume":"162","author":"Mori","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib116","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaad.2007.12.002","article-title":"Clinical differences between atopic and atopiform dermatitis","volume":"58","author":"Brenninkmeijer","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib117","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaci.2013.04.046","article-title":"Intrinsic atopic dermatitis shows similar T(H)2 and higher T(H)17 immune activation compared with extrinsic atopic dermatitis","volume":"132","author":"Suarez-Farinas","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib118","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib119","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.4049\/jimmunol.181.7.4733","article-title":"Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis","volume":"181","author":"Kryczek","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib120","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jaci.2009.03.041","article-title":"IL-22-producing \u201cT22\u201d T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells","volume":"123","author":"Nograles","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib121","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1038\/jid.2008.111","article-title":"Possible pathogenic role of Th17 cells for atopic dermatitis","volume":"128","author":"Koga","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib122","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jdermsci.2013.07.009","article-title":"High frequencies of positive nickel\/cobalt patch tests and high sweat nickel concentration in patients with intrinsic atopic dermatitis","volume":"72","author":"Yamaguchi","year":"2013","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2014.03.006_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2010.02.008","article-title":"Extrinsic and intrinsic types of atopic dermatitis","volume":"58","author":"Tokura","year":"2010","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2014.03.006_bib124","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2500\/aap.2006.27.2887","article-title":"Immune dysregulation in atopic dermatitis","volume":"27","author":"Miraglia del Giudice","year":"2006","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2014.03.006_bib125","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/sj.jid.5700630","article-title":"Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis","volume":"127","author":"Weidinger","year":"2007","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib126","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1365-2222.2003.01803.x","article-title":"Immunological differences between intrinsic and extrinsic types of atopic dermatitis","volume":"33","author":"Akdis","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2014.03.006_bib127","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.4049\/jimmunol.159.9.4611","article-title":"Skin-homing, CLA(+) memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA(-) memory T cells","volume":"159","author":"Akdis","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib128","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jaci.2012.11.010","article-title":"Residual genomic signature of atopic dermatitis despite clinical resolution with narrow-band UVB","volume":"131","author":"Suarez-Farinas","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.03.006_bib129","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archdermatol.2007.22","article-title":"A\u00a0retrospective case series review of the peroxisome proliferator-activated receptor ligand rosiglitazone in the treatment of atopic dermatitis","volume":"144","author":"Behshad","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5021\/ad.2010.22.1.9","article-title":"The efficacy and safety of long-term oral cyclosporine treatment for patients with atopic dermatitis","volume":"22","author":"Haw","year":"2010","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib131","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1517\/14712598.2013.782391","article-title":"Anti-IgE: emerging opportunities for Omalizumab","volume":"13","author":"Babu","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jaip.2014.03.006_bib132","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/1744-9987.12047","article-title":"Double-filtration plasmapheresis for the treatment of patients with recalcitrant atopic dermatitis","volume":"17","author":"Kim","year":"2013","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jaip.2014.03.006_bib133","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/jid.2008.85","article-title":"T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis","volume":"128","author":"Blauvelt","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib134","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/jid.2009.399","article-title":"Circulating Th17, Th22, and Th1 cells are increased in psoriasis","volume":"130","author":"Kagami","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2014.03.006_bib135","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1038\/jid.2012.184","article-title":"Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis","volume":"132","author":"Suarez-Farinas","year":"2012","journal-title":"J\u00a0Invest Dermatol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321981400097X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321981400097X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:07:31Z","timestamp":1761973651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221321981400097X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":135,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S221321981400097X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2014.03.006","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin Barrier and Immune Dysregulation in Atopic Dermatitis: An Evolving Story with Important Clinical Implications","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2014.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}